EXPD:NYSEExpeditors International of Washington, Inc. Analysis
Data as of 2026-09-08 - not real-time
$185.96
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
The moving-average structure behind Expeditors International of Washington, Inc. is bullish at $185.96, with short-term averages leading the long-term ones. The last 30 days have gained 8.5%. Momentum indicators put RSI at 53.6 (neutral) with MACD reading bearish. The recent range runs from support at $176.79 up to resistance at $192.28.
Valuation screens as overvalued: a P/E of 27.1 sits in line with the sector average of 28.3. Analyst price targets sit 4.4% below the current price. Revenue is growing at 32.1% on a 7.6% profit margin. The 0.86% dividend yield looks covered by current payout levels.
Risk scores 4 out of 10, which is moderate for this asset class. With 30-day volatility of 25.5%, a beta of 0.50 and a maximum drawdown of 15.9%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
Valuation screens as overvalued: a P/E of 27.1 sits in line with the sector average of 28.3. Analyst price targets sit 4.4% below the current price. Revenue is growing at 32.1% on a 7.6% profit margin. The 0.86% dividend yield looks covered by current payout levels.
Risk scores 4 out of 10, which is moderate for this asset class. With 30-day volatility of 25.5%, a beta of 0.50 and a maximum drawdown of 15.9%, position sizing matters here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
All three time horizons resolve to hold, carrying 3/10 conviction.
Top Market Events
On August 4, Expeditors International of Washington NYSE:EXPD reported second-quarter 2026 results that blew past the...Expeditors International EXPD delivered earnings and revenue surprises of +20.Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 158.95
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- Short-term moving averages stacked above long-term ones
- P/E of 27.1 versus sector average of 28.3
- Trading above the 200-day average of 158.95
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 27.1 versus sector average of 28.3
- Revenue growth of +32.1%
- Return on equity of 42.7%
Key Metrics & Analysis
Financial Health
Revenue Growth32.10%
Profit Margin7.63%
P/E Ratio27.1
ROE42.67%
ROA15.23%
Debt/Equity26.75
P/B Ratio11.4
Op. Cash Flow$972.5M
Free Cash Flow$797.6M
Industry P/E28.3
Technical Analysis
TrendBullish
RSI53.6
Support$176.79
Resistance$192.28
MA 20$187.19
MA 50$178.80
MA 200$158.95
MACDBearish
VolumeStable
Fear & Greed Index93.36
Valuation
Fair Value$214.97
Target Price$177.71
Upside/Downside-4.43%
GradeOvervalued
TypeGrowth
Dividend Yield0.86%
Risk Assessment
Beta0.50
Volatility25.47%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.